Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Ming Zhou

Showing results (41-50 of 190) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|August 30, 2012
Scaling the druggability landscape of human bromodomains, a new class of drug targetsGuangtao Zhang, Roberto Sanchez, Ming-Ming Zhou
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Modulating molecular functions of p53 with small moleculesShiraz Mujtaba, Lei Zeng, Ming-Ming Zhou
Frontiers in Molecular Biosciences|September 20, 2021
The Functions of BET Proteins in Gene Transcription of Biology and DiseasesKa Lung Cheung, Claudia Kim, Ming-Ming Zhou
Yi Chuan = Hereditas|December 28, 2005
[Molecular evidence for origin of plastid-like organelle apicoplast: a review]Xin-Yu Zhu, Yao Zhang, Ming-Ming Zhou
Chemical Reviews|October 24, 2015
Discovery of Chemical Inhibitors of Human BromodomainsGuangtao Zhang, Steven G Smith, Ming-Ming Zhou
Cancer Research|August 11, 2011
Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expressionFrancesca Aguilo, Ming-Ming Zhou, Martin J Walsh
Chemistry & Biology|April 22, 2014
Privileged diazepine compounds and their emergence as bromodomain inhibitorsSteven G Smith, Roberto Sanchez, Ming-Ming Zhou
FEBS Letters|March 26, 2002
PTB or not PTB -- that is the questionKelley S Yan, Miklos Kuti, Ming Ming Zhou
Plos One|February 27, 2009
Computer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis preventionPratima Chaurasia, Mihaly Mezei, Ming-Ming Zhou, et al.
Trends in Pharmacological Sciences|October 29, 2025
Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiersWenju Zhang, Yumei Li, Ming-Ming Zhou, et al.
Pageof 19

Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|August 30, 2012
Scaling the druggability landscape of human bromodomains, a new class of drug targetsGuangtao Zhang, Roberto Sanchez, Ming-Ming Zhou
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Modulating molecular functions of p53 with small moleculesShiraz Mujtaba, Lei Zeng, Ming-Ming Zhou
Frontiers in Molecular Biosciences|September 20, 2021
The Functions of BET Proteins in Gene Transcription of Biology and DiseasesKa Lung Cheung, Claudia Kim, Ming-Ming Zhou
Yi Chuan = Hereditas|December 28, 2005
[Molecular evidence for origin of plastid-like organelle apicoplast: a review]Xin-Yu Zhu, Yao Zhang, Ming-Ming Zhou
Chemical Reviews|October 24, 2015
Discovery of Chemical Inhibitors of Human BromodomainsGuangtao Zhang, Steven G Smith, Ming-Ming Zhou
Cancer Research|August 11, 2011
Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expressionFrancesca Aguilo, Ming-Ming Zhou, Martin J Walsh
Chemistry & Biology|April 22, 2014
Privileged diazepine compounds and their emergence as bromodomain inhibitorsSteven G Smith, Roberto Sanchez, Ming-Ming Zhou
FEBS Letters|March 26, 2002
PTB or not PTB -- that is the questionKelley S Yan, Miklos Kuti, Ming Ming Zhou
Plos One|February 27, 2009
Computer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis preventionPratima Chaurasia, Mihaly Mezei, Ming-Ming Zhou, et al.
Trends in Pharmacological Sciences|October 29, 2025
Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiersWenju Zhang, Yumei Li, Ming-Ming Zhou, et al.
Pageof 19